asagart@cooley.com
Arman Sagart represents public and privately-held companies in corporate and securities matters, including private financings, public offerings, mergers and acquisitions, SEC reporting and corporate governance.
Download full bio
Red Tree Venture Capital – $108 Million Oversubscribed Series B Financing
CinCor Pharma to Sell to AstraZeneca for Approximately $1.8 Billion
Horizon Therapeutics to Be Acquired by Amgen for Approximately $28 Billion
Biotech Company ViaCyte to Be Acquired by Vertex Pharmaceuticals
Emerging Companies
Public Companies
Mergers & Acquisitions
Capital Markets
Surfing
Hiking
Football
Traveling
University of California at Los Angeles School of LawJD, 2021
University of California, Los AngelesBA, Communicationscum laude, 2018
California
CinCor Pharma to Sell to AstraZeneca for Approximately $1.8 Billion January 9, 2023
Horizon Therapeutics to Be Acquired by Amgen for Approximately $28 Billion December 12, 2022
Biotech Company ViaCyte to Be Acquired by Vertex Pharmaceuticals July 13, 2022
First Place UCLA Transactional Law Competition (Negotiation and Drafting)
UCLA Law Achievement Fellow
+1 858 550 6288
Locations